Jeff Getty: Lessons in desperate measures

Jeff Getty in 1996 Jeff Getty: Lessons in desperate measures By Gail Dutton FEATURE ARTICLES The Elite Controllers of HIVGAIL DUTTON reports from San Francisco on how infected nonprogressors - also known as elite controllers - are providing clues to the control, and potentially the eradication, of HIV. 25 Years with HIV ARTICLE EXTRAS HIV Shows ItselfA 1981 report in the MMWR marks the beginning The Impact of HIVIts progressions, 1981-2006 and beyond Why Monkeys

Written byGail Dutton
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Jeff Getty in 1996

Jeff Getty:
Lessons in desperate measures
By Gail Dutton

Steven G. Deeks has been known for gutsy approaches, starting in the dark days of the mid-1990s. "1993 was the low point, the worst, of the epidemic," Deeks remembers. "Everyone was dying." His first day in the clinic coincided with the release of a major clinical study, the Concorde study, which investigated the use of early AZT therapy in 1,749 asymptomatic patients and showed that it didn't work. Little was forthcoming by way of replacements. Hospices and hospitals were full, Deeks says. "So we got very, very desperate."

In 1994 Deeks got involved with the Dobson Project, a West coast immunology think tank that activists had founded. Based on lim-ited evidence, a multicenter group, including Deeks and Dobson Project member Paul Volberding (now at San Francisco Veterans' Administration Medical Center), performed a bone marrow transplant from a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies